5AM Venture Management as of June 30, 2024
Portfolio Holdings for 5AM Venture Management
5AM Venture Management holds 28 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Skye Bioscience Com New (SKYE) | 18.2 | $82M | 10M | 8.01 | |
Entrada Therapeutics (TRDA) | 14.1 | $63M | 4.4M | 14.25 | |
Enliven Therapeutics (ELVN) | 13.6 | $61M | 2.6M | 23.37 | |
Dianthus Therapeutics (DNTH) | 7.1 | $32M | 1.2M | 25.88 | |
Celldex Therapeutics Com New (CLDX) | 4.1 | $18M | 497k | 37.01 | |
Biohaven (BHVN) | 3.6 | $16M | 470k | 34.71 | |
Tyra Biosciences (TYRA) | 3.4 | $15M | 939k | 15.99 | |
Pharvaris N V (PHVS) | 3.4 | $15M | 798k | 18.80 | |
Praxis Precision Medicines I Com New (PRAX) | 3.1 | $14M | 340k | 41.36 | |
Erasca (ERAS) | 2.9 | $13M | 5.4M | 2.36 | |
Viking Therapeutics (VKTX) | 2.8 | $13M | 238k | 53.01 | |
Moonlake Immunotherapeutics Class A Ord (MLTX) | 2.8 | $12M | 282k | 43.97 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.5 | $11M | 1.2M | 9.03 | |
Tectonic Therapeutic (TECX) | 2.4 | $11M | 647k | 16.47 | |
Miragen Therapeutics (VRDN) | 2.1 | $9.6M | 737k | 13.01 | |
Silence Therapeutics Ads (SLN) | 2.0 | $9.0M | 476k | 19.00 | |
Anaptysbio Inc Common (ANAB) | 2.0 | $9.0M | 358k | 25.06 | |
Gh Research Ordinary Shares (GHRS) | 1.5 | $6.7M | 573k | 11.66 | |
Cogent Biosciences (COGT) | 1.5 | $6.7M | 790k | 8.43 | |
Vor Biopharma (VOR) | 1.4 | $6.4M | 6.4M | 1.00 | |
Scpharmaceuticals (SCPH) | 1.2 | $5.2M | 1.2M | 4.35 | |
Rallybio Corp (RLYB) | 1.1 | $4.9M | 3.6M | 1.34 | |
Q32 Bio (QTTB) | 1.0 | $4.5M | 252k | 17.95 | |
Adverum Biotechnologies Com New (ADVM) | 0.8 | $3.7M | 542k | 6.86 | |
Mersana Therapeutics (MRSN) | 0.6 | $2.6M | 1.3M | 2.01 | |
Zentalis Pharmaceuticals (ZNTL) | 0.4 | $2.0M | 490k | 4.09 | |
Cidara Therapeutics (CDTX) | 0.2 | $677k | 57k | 11.94 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 0.1 | $435k | 50k | 8.70 |